Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Biomarker Discovery Services In Europe
11 services found
Manufactured by:Exosome Diagnostics, Inc. based inWaltham, MASSACHUSETTS (USA)
Exosome Diagnostics partners with biopharma companies and Clinical Centers of Excellence to facilitate biomarker discovery programs in support of early discovery, translational, and clinical programs that may have companion diagnostic development needs. ...
by:Almac Group based inCraigavon, UNITED KINGDOM
Almac Diagnostic Services can also help Biopharma clients validate reliable Pharmacodynamic (PD) Biomarker assays that can help provide invaluable guidance within their drug development programmes. Almac also has extensive experience in the discovery of clinically applicable biomarkers, through our own range of Almac proprietary assays (DDIR, ...
by:Indivumed GmbH based inHamburg, GERMANY
Biomarkers are important when it comes to the development of novel drugs and mechanisms and are also gaining importance as companion diagnostic ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Invicro’s Advanced Pathology Services (APS) team provides end-to-end solutions to support translational and clinical research by providing a combination of routine and unique tissue testing services. As part of the REALM IDx, Inc. group, our pathology service laboratories support projects spanning preclinical biomarker discovery research to clinical trials ...
Manufactured by:Veracyte based inMarseille Cedex 9, FRANCE
Veracyte’s professional framework for clinical trial assay (CTA) and companion diagnostics (CDx) development allows our clients to confidently advance priority projects. With an end-to-end service infrastructure, we support all aspects of assay development, manufacturing, life cycle management, regulatory submissions, marketing support, and commercialization for our ...
by:Almac Group based inCraigavon, UNITED KINGDOM
Almac has extensive expertise in the development of biomarker assays for commercial partners across a wide range of ...
Manufactured by:Owlstone Medical Ltd. based inCambridge, UNITED KINGDOM
Developing Breath Biopsy for clinical applications in early detection and precision ...
Manufactured by:Firalis Group based inHuningue, FRANCE
The successful implementation of a biomarker endpoint is highly dependent on the availability of assays and on reliable measurements of markers in biological samples. While a large number of assays are on the market, scientists often have an urgent need for assays meeting specific ...
by:Cmbio based inCopenhagen, DENMARK
At Cmbio, we offer both shallow and deep shotgun sequencing options to suit the specific requirements of your study. Whether you're conducting exploratory research, clinical trials, or large-scale population studies, our services are designed to deliver accurate, high-quality data that empowers your ...
Manufactured by:Bio-Me based inOslo, NORWAY
PMP™ technology – Bridging the gap between clinical research and clinical practice by translating knowledge into actionable information. Microbiome Analysis Services for Pharma and Drug Developers. Bio-Me’s Precision Microbiome Profiling (PMP™) technology, based on qPCR, is perfectly positioned to support drug developers in their development pipeline and successful market ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Unlocking the potential of precision medicine with Artificial Intelligence – enabled data-driven insights. Advance targeted therapy development by harnessing the power of data and multimodal analytics. Advances in molecular and imaging techniques have resulted in an explosion of data, providing an unprecedented opportunity to identify clinically relevant drug targets. Yet, deciphering and ...